Penumbra reports THUNDER study results for THUNDERBOLT stroke device

Reuters2026/07/22 18:35

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Penumbra released THUNDER IDE study results for its THUNDERBOLT computer-assisted vacuum thrombectomy system in ELVO stroke.
Study met its performance goal, with 87.5% achieving successful reperfusion (mTICI 2b-3); first-pass success was 64.8%.
Median time to revascularization was 20 minutes; serious device or procedure-related adverse events were 2.8%.
Penumbra said THUNDERBOLT has received US FDA clearance and a CE mark.
Full release: https://www.penumbrainc.com/

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Penumbra Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607221435PR_NEWS_USPR_____SF10287) on July 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Penumbra reports THUNDER study results for THUNDERBOLT stroke device

You may also like

Crypto prices